Crinetics Pharmaceuticals Insider Trades

CRNX

Track insider trading activity from Crinetics Pharmaceuticals executives and directors. See which insiders are buying and selling CRNX stock.

Trades Last 12 Months

All Insider Trades for Crinetics Pharmaceuticals

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nichols Weston Director
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.2M 132,305 shares
$84.95
$84.95
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.2M 132,305 shares
$84.95
$84.95
Betz Stephen F. Chief Scientific Officer
Holding Value $6.77M 79,650 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$76.9M 905,240 shares
$84.95
$84.95
Deardorf Caren Director
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.49M 111,680 shares
$84.95
$84.95
Schilke Tobin Chief Financial & Infra. Ofcr.
Holding Value $6.07M 71,471 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$17.8M 209,427 shares
$84.95
$84.95
Wierenga Wendell Director
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$19.7M 232,151 shares
$84.95
$84.95
Fust Matthew K Director
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.88M 80,933 shares
$84.95
$84.95
Okey Stephanie Director
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.97M 117,405 shares
$84.95
$84.95
Struthers Richard Scott President & CEO
Holding Value $15M 176,663 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$201M 2,364,528 shares
$84.95
$84.95
Kalofonos Isabel Chief Commercial Officer
Holding Value $2.89M 34,000 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16M 188,169 shares
$84.95
$84.95
Holding Value $503k 5,925 shares
Last Trade
Sep 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.6M 113,055 shares
$84.95
$84.95
Knight Jeff E. Chief Dev. & Operating Officer
Holding Value $8.94M 105,289 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.42M 85,163 shares
$40.10
$84.95
Pizzuti Dana Chief Med And Dev Officer
Holding Value $6.1M 71,837 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 5,000 shares
$45.25
$84.95
Wierenga Wendall Director
Holding Value $9.87M 116,146 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$84.95
Hassard James Chief Commercial Officer
Holding Value $3.76M 44,259 shares
Last Trade
Jul 05, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$657k 15,000 shares
$43.83
$84.95
Krasner Alan Seth Chief Medical Officer
Holding Value $13M 153,473 shares
Last Trade
Oct 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$201k 7,000 shares
$28.69
$84.95
Edelman Joseph Director
Holding Value $452M 5,321,032 shares
Last Trade
Apr 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.5M 157,515 shares
$22.22
$84.95
Holding Value $452M 5,321,032 shares
Last Trade
Apr 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.5M 157,515 shares
$22.22
$84.95
Madan Ajay Chief Development Officer
Holding Value $15M 176,995 shares
Last Trade
Mar 01, 2022 Purchase (Open Market)Shares sold on the open market or in a private sale.
$179k 9,000 shares
$19.88
$84.95
Kaldor Stephen W Director
Holding Value $1.06M 12,500 shares
Last Trade
Jun 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 12,500 shares
$23.23
$84.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up